Lynn Mehler will chair Paul Hastings' life sciences regulatory practice. She and Phil Katz join the firm from Hogan Lovells.

A controversial 2010 study that suggested bacteria could grow using arsenic instead of phosphorus has been retracted by the research journal Science. When you purchase through links on our site, we ...

Analysis of ~50 million articles published in ~50 thousand journals demonstrates that journals have become more diverse in terms of both interdisciplinarity and internationalization but with some ...

Pioneering life sciences journal eLife finds itself at the center of a white-hot furor after its governing board fired editor-in-chief Michael Eisen following his endorsement on social media of a ...

Conventional wisdom says that most retractions of papers in scientific journals are triggered by unintentional errors. Not so, according to one of the largest-ever studies of retractions. A survey ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Over the past 150 years, humanity has unleashed unimaginable energy by splitting ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min About 42% of the Big Apple's ...

The demand for life sciences patent attorneys continues to rise as biotechnology, pharmaceuticals, medical devices, and health-focused innovation expand across ...

The real estate investment trust has been dealing with challenges in the life-sciences market, and its strategy includes selling off certain types of assets while focusing on a different part of its ...